Correspondence 0001213900-23-009298 from INTENSITY THERAPEUTICS, INC. (INTS)
INTENSITY THERAPEUTICS, INC.
Date: Feb. 8, 2023 · CIK: 0001567264 · Accession: 0001213900-23-009298
AI Filing Summary & Sentiment
File numbers found in text: 333-260565
Show Raw Text
CORRESP
1
filename1.htm
February 8, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Intensity Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-260565
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence
via EDGAR on February 6, 2023, in which we, as representative of the several underwriters of Intensity Therapeutics, Inc.’s proposed
public offering, joined Intensity Therapeutics, Inc.’s request for acceleration of the effective date of the above-referenced Registration
Statement for February 8, 2023, at 4:30 p.m. Eastern Time. Intensity Therapeutics, Inc. is no longer requesting that such Registration
Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
THE
BENCHMARK COMPANY, LLC
As representative of the
several Underwriters
By:
/s/ Michael Jacobs
Name:
Michael Jacobs
Title:
MD/Head of ECM